GCP: A Question & Answer Reference Guide to be included in the informed consent document: "A description of this clinical trial will be available on http:// www.ClinicalTrials.gov, as required by U.S. Law. This Web site will not include information that can identify you. At most, the Web site will include a summary of the results. You can search this Web site at any time." While there are no direct mandates from the FDA to provide individual subjects with their results, the 2015 Perceptions and Insights study conducted by CISCRP (www.ciscrp.org) reported that 73% of the 3,152 survey respondents indicate that they would be interested in receiving a summery of the study results while 55% noted they would like to know the cohort or study group to which they were assigned. Additional areas of interest included knowing the drug approval status as well as the study drug marketed name with 44% and 38% of respondents respectively, indicating interest in knowing this information post participation. Given the interest noted by research subjects and in the spirit of the growing patient centricity movement, Getz and Hallinan provide further information and guidelines on the process in their article "Creating a Standard Practice for Communicating Lay Language Trial Results to Study Volunteers". (Research Practitioner, Retrieved from: https://www.ciscrp.org/download/a-standard-practice-for-communicating-trial-results/?wpdmdl=5106). 468http://www.ClinicalTrials.gov http://www.ClinicalTrials.gov http://www.ciscrp.org https://www.ciscrp.org/download/a-standard-practice-for-communicating-trial-results/?wpdmdl=5106